New immunotherapy cocktail takes on stubborn colorectal cancer
Disease control
Recruiting now
This early-phase trial is testing whether combining two immunotherapy drugs—nadunolimab and toripalimab—can help people with metastatic colorectal cancer that no longer responds to chemotherapy. The study will enroll 24 participants and first check for safety, then measure how ma…
Phase: PHASE1, PHASE2 • Sponsor: Dan Feng • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC